光正眼科
(002524)
| 流通市值：21.14亿 | | | 总市值：21.39亿 |
| 流通股本：5.09亿 | | | 总股本：5.15亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 390,144,820.93 | 187,042,350.77 | 885,181,180.03 | 663,491,611.66 |
| 营业总成本 | 386,767,624.74 | 190,984,978.41 | 892,198,398.94 | 669,323,200.43 |
| 其他经营收益 | | | | |
| 营业利润 | 27,636,230.4 | -756,305.93 | 4,317,102.38 | 7,758,876.53 |
| 利润总额 | 24,421,047.98 | -972,470.09 | -1,656,883.5 | 5,151,420.16 |
| 净利润 | 17,792,185.18 | -3,842,455.34 | -19,671,149.03 | 380,006.44 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 17,792,185.18 | -3,842,455.34 | -19,671,149.03 | 380,006.44 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 234,495,991.04 | 238,540,939.11 | 257,633,817.98 | 262,775,989.3 |
| 非流动资产: | | | | |
| 非流动资产合计 | 907,906,130.44 | 945,252,747.64 | 924,262,146.84 | 950,787,038.26 |
| 资产总计 | 1,142,402,121.48 | 1,183,793,686.75 | 1,181,895,964.82 | 1,213,563,027.56 |
| 流动负债: | | | | |
| 流动负债合计 | 652,465,227.62 | 714,278,931.31 | 730,974,315.46 | 728,779,673.84 |
| 非流动负债: | | | | |
| 非流动负债合计 | 377,822,849.36 | 373,229,957.28 | 350,810,888.81 | 358,087,729.12 |
| 负债合计 | 1,030,288,076.98 | 1,087,508,888.59 | 1,081,785,204.27 | 1,086,867,402.96 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 112,510,940.79 | 92,057,251.64 | 95,788,100.97 | 121,949,271.85 |
| 股东权益合计 | 112,114,044.5 | 96,284,798.16 | 100,110,760.55 | 126,695,624.6 |
| 负债和股东权益合计 | 1,142,402,121.48 | 1,183,793,686.75 | 1,181,895,964.82 | 1,213,563,027.56 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 392,567,395.99 | 200,448,064.66 | 882,256,621.02 | 639,525,045.79 |
| 经营活动现金流出小计 | 361,264,714.26 | 193,378,315.78 | 757,530,655.22 | 585,819,498.9 |
| 经营活动产生的现金流量净额 | 31,302,681.73 | 7,069,748.88 | 124,725,965.8 | 53,705,546.89 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 20,805,124.16 | 357,788 | 14,040,752.13 | 11,616,094.04 |
| 投资活动现金流出小计 | 4,980,550.17 | 2,654,261.67 | 29,039,668.79 | 16,004,841.73 |
| 投资活动产生的现金流量净额 | 15,824,573.99 | -2,296,473.67 | -14,998,916.66 | -4,388,747.69 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 210,900,000 | 101,000,000 | 358,300,000 | 270,300,000 |
| 筹资活动现金流出小计 | 261,933,780.43 | 109,918,009.74 | 487,147,812.38 | 345,272,697.4 |
| 筹资活动产生的现金流量净额 | -51,033,780.43 | -8,918,009.74 | -128,847,812.38 | -74,972,697.4 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -3,906,524.71 | -4,144,734.53 | -19,120,763.24 | -25,655,898.2 |
| 期末现金及现金等价物余额 | 41,008,678.38 | 40,770,468.56 | 44,915,203.09 | 38,380,068.13 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -3,906,524.71 | - | -19,120,763.24 | - |